Dr. Steven Schechter, MD

Dr. Schechter practices at Brown Surgical Associates - HOPD in Providence, Rhode Island.

Dr. Schechter's NPI, 1740241876, was assigned on March 29, 2006. Dr. Schechter graduated from University of Rochester Medical Center in 1985. Dr. Schechter holds Rhode Island license MD07432.

Dr. Schechter's primary practice is Brown Surgical Associates - HOPD, at 208 Collyer St, Providence, RI 02904.

Dr. Schechter's primary practice is Brown Surgical Associates - HOPD in Providence, Rhode Island. Dr. Schechter is also affiliated with The Miriam Hospital. The medical group on file is Brown Surgical Associates. Dmand AI also links Dr. Schechter to 2 more hospitals, 5 group practices and clinics and 4 medical groups, each named with a free account. Dr. Schechter's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schechter practices, 9 sites in all. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Schechter's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Schechter is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Dr. Schechter's licenses on file in 3 states: Rhode Island, Massachusetts and New Jersey.

Dmand AI lists colonoscopy, colon removal, gastrointestinal obstruction and hemorrhoids among the conditions Dr. Schechter treats.

CMS data shows 258 Medicare services from Dr. Schechter across 9 procedure codes in 2024, for 220 Medicare patients. Medicare paid $22,185 for them.

CMS counts 220 Medicare patients who saw Dr. Schechter in 2024. The largest group is 65 to 74, with 96 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schechter's median patient age at 70, with 48% women.

In 2024, Dr. Schechter wrote 153 Medicare Part D claims for 76 patients. 91% of them were for generic drugs. CMS names the drug for 91 of them, across 5 drugs with 11 or more claims each, at $2,040 in total drug cost. In 2023, CMS named 101 claims across 6 drugs.

Dr. Schechter accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schechter as offering telehealth. CMS counts 13 procedures of removal or shaving of skin growth by Dr. Schechter, more than 66% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 17 papers to Dr. Schechter, published from 2013 to 2023. 2018 was the busiest year, with 3. The most frequent topics are Anus Neoplasms, Anal Canal and Genital Neoplasms, Female. Dr. Schechter has published most often in Am Surg. Dr. Schechter's most frequent co-authors are Adam Augustus Klipfel, MD, Matthew Daniel Vrees, MD and Amy J. Bregar, MD.

Dmand AI links Dr. Schechter to 1 clinical trial.

CMS Open Payments shows 92 general payments to Dr. Schechter from 19 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 93% of the total. Davol Inc. paid the most, $43,831.

Dmand AI lists 7 awards for Dr. Schechter, most recently President in 2022.

Dr. Schechter graduated from University of Rochester Medical Center in 1985. Dr. Schechter is a member of ACS and ASCRS.

Dr. Schechter is in network with 17 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.